Kiora Pharmaceuticals, Inc.
KPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $11,488 | $12,693 | $9,903 |
| - Cash | $5,509 | $1,028 | $3,771 | $3,792 |
| + Debt | $248 | $430 | $159 | $57 |
| Enterprise Value | – | $10,891 | $9,081 | $6,167 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$38 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$578 | -$2,255 | -$2,055 | -$2,400 |
| % Margin | – | – | – | – |
| Net Income | $27 | -$2,152 | -$2,193 | -$4,224 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.01 | -0.54 | -0.52 | -1.41 |
| % Growth | 101.9% | -3.8% | 63.1% | – |
| Operating Cash Flow | -$1,273 | -$3,803 | -$2,704 | -$2,252 |
| Capital Expenditures | -$0 | -$32 | $0 | $45 |
| Free Cash Flow | -$1,274 | -$3,836 | -$2,704 | -$2,207 |